Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Condition: Tuberculosis Intervention: Drug: Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine. Sponsor: Beijing Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2020 Category: Research Source Type: clinical trials
Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Community-Acquired and Nosocomial Pneumonia
Condition: Pneumonia Interventions: Drug: Continuous infusion Linezolid; Drug: intermittent dosing linezolid Sponsors: October 6 University; Beni-Suef University; Critical Care Department,Cairo University Hospitals Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials